nodes	percent_of_prediction	percent_of_DWPC	metapath
Drospirenone—PTGS2—esophageal cancer	0.522	1	CbGaD
Drospirenone—BCHE—Cisplatin—esophageal cancer	0.158	0.565	CbGbCtD
Drospirenone—PTGS2—Cisplatin—esophageal cancer	0.122	0.435	CbGbCtD
Drospirenone—BCHE—diaphragm—esophageal cancer	0.0175	0.277	CbGeAlD
Drospirenone—NR3C2—bronchus—esophageal cancer	0.00273	0.0432	CbGeAlD
Drospirenone—NR3C2—smooth muscle tissue—esophageal cancer	0.00267	0.0423	CbGeAlD
Drospirenone—PGR—epithelium—esophageal cancer	0.00258	0.0408	CbGeAlD
Drospirenone—PGR—smooth muscle tissue—esophageal cancer	0.00248	0.0393	CbGeAlD
Drospirenone—NR3C2—trachea—esophageal cancer	0.00245	0.0388	CbGeAlD
Drospirenone—NR3C2—digestive system—esophageal cancer	0.00211	0.0334	CbGeAlD
Drospirenone—AR—epithelium—esophageal cancer	0.00205	0.0325	CbGeAlD
Drospirenone—AR—bronchus—esophageal cancer	0.00202	0.032	CbGeAlD
Drospirenone—AR—smooth muscle tissue—esophageal cancer	0.00198	0.0313	CbGeAlD
Drospirenone—Thromboembolic event—Capecitabine—esophageal cancer	0.00184	0.107	CcSEcCtD
Drospirenone—Infarction—Capecitabine—esophageal cancer	0.00179	0.104	CcSEcCtD
Drospirenone—NR3C2—lung—esophageal cancer	0.00176	0.0279	CbGeAlD
Drospirenone—BCHE—bronchus—esophageal cancer	0.00164	0.0261	CbGeAlD
Drospirenone—PGR—lung—esophageal cancer	0.00164	0.0259	CbGeAlD
Drospirenone—BCHE—smooth muscle tissue—esophageal cancer	0.00161	0.0255	CbGeAlD
Drospirenone—AR—digestive system—esophageal cancer	0.00156	0.0247	CbGeAlD
Drospirenone—BCHE—trachea—esophageal cancer	0.00148	0.0234	CbGeAlD
Drospirenone—Hydrocortisone—ANXA1—esophageal cancer	0.00139	0.207	CrCbGaD
Drospirenone—Thromboembolic event—Methotrexate—esophageal cancer	0.00137	0.0797	CcSEcCtD
Drospirenone—Testolactone—CYP19A1—esophageal cancer	0.00133	0.198	CrCbGaD
Drospirenone—AR—lung—esophageal cancer	0.0013	0.0207	CbGeAlD
Drospirenone—PTGS2—epithelium—esophageal cancer	0.00129	0.0204	CbGeAlD
Drospirenone—BCHE—digestive system—esophageal cancer	0.00127	0.0201	CbGeAlD
Drospirenone—PTGS2—bronchus—esophageal cancer	0.00127	0.0201	CbGeAlD
Drospirenone—PTGS2—smooth muscle tissue—esophageal cancer	0.00124	0.0196	CbGeAlD
Drospirenone—NR3C2—lymph node—esophageal cancer	0.0012	0.0191	CbGeAlD
Drospirenone—PTGS2—trachea—esophageal cancer	0.00114	0.018	CbGeAlD
Drospirenone—PGR—lymph node—esophageal cancer	0.00112	0.0177	CbGeAlD
Drospirenone—BCHE—lung—esophageal cancer	0.00106	0.0168	CbGeAlD
Drospirenone—PTGS2—digestive system—esophageal cancer	0.000979	0.0155	CbGeAlD
Drospirenone—AR—lymph node—esophageal cancer	0.000892	0.0141	CbGeAlD
Drospirenone—PTGS2—lung—esophageal cancer	0.000818	0.013	CbGeAlD
Drospirenone—Loss of libido—Methotrexate—esophageal cancer	0.000799	0.0465	CcSEcCtD
Drospirenone—Embolism—Capecitabine—esophageal cancer	0.000772	0.0449	CcSEcCtD
Drospirenone—BCHE—lymph node—esophageal cancer	0.000726	0.0115	CbGeAlD
Drospirenone—Thrombosis—Capecitabine—esophageal cancer	0.0007	0.0407	CcSEcCtD
Drospirenone—Spironolactone—ABCC2—esophageal cancer	0.000652	0.097	CrCbGaD
Drospirenone—Embolism—Methotrexate—esophageal cancer	0.000575	0.0334	CcSEcCtD
Drospirenone—PTGS2—lymph node—esophageal cancer	0.000559	0.00886	CbGeAlD
Drospirenone—Methyltestosterone—CYP19A1—esophageal cancer	0.000541	0.0805	CrCbGaD
Drospirenone—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000498	0.029	CcSEcCtD
Drospirenone—Progesterone—CYP1B1—esophageal cancer	0.000452	0.0673	CrCbGaD
Drospirenone—Breast disorder—Cisplatin—esophageal cancer	0.000441	0.0256	CcSEcCtD
Drospirenone—Testosterone—CYP1B1—esophageal cancer	0.000428	0.0636	CrCbGaD
Drospirenone—Megestrol acetate—ABCB1—esophageal cancer	0.000386	0.0574	CrCbGaD
Drospirenone—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000371	0.0216	CcSEcCtD
Drospirenone—Myocardial infarction—Cisplatin—esophageal cancer	0.000369	0.0214	CcSEcCtD
Drospirenone—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000367	0.0213	CcSEcCtD
Drospirenone—Migraine—Capecitabine—esophageal cancer	0.000354	0.0206	CcSEcCtD
Drospirenone—Progesterone—CYP2A6—esophageal cancer	0.000349	0.0519	CrCbGaD
Drospirenone—Mood swings—Capecitabine—esophageal cancer	0.000341	0.0198	CcSEcCtD
Drospirenone—Breast disorder—Capecitabine—esophageal cancer	0.000325	0.0189	CcSEcCtD
Drospirenone—Testosterone—CYP19A1—esophageal cancer	0.000314	0.0467	CrCbGaD
Drospirenone—Depression—Capecitabine—esophageal cancer	0.000277	0.0161	CcSEcCtD
Drospirenone—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000273	0.0159	CcSEcCtD
Drospirenone—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000273	0.0159	CcSEcCtD
Drospirenone—Myocardial infarction—Capecitabine—esophageal cancer	0.000272	0.0158	CcSEcCtD
Drospirenone—Mood swings—Methotrexate—esophageal cancer	0.000254	0.0148	CcSEcCtD
Drospirenone—Haemoglobin—Capecitabine—esophageal cancer	0.00025	0.0145	CcSEcCtD
Drospirenone—Haemorrhage—Capecitabine—esophageal cancer	0.000249	0.0145	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000249	0.0144	CcSEcCtD
Drospirenone—Breast disorder—Methotrexate—esophageal cancer	0.000242	0.0141	CcSEcCtD
Drospirenone—Spironolactone—ABCB1—esophageal cancer	0.00024	0.0357	CrCbGaD
Drospirenone—Erythema multiforme—Capecitabine—esophageal cancer	0.000235	0.0137	CcSEcCtD
Drospirenone—Nervous system disorder—Cisplatin—esophageal cancer	0.000235	0.0137	CcSEcCtD
Drospirenone—Skin disorder—Cisplatin—esophageal cancer	0.000233	0.0135	CcSEcCtD
Drospirenone—Angiopathy—Capecitabine—esophageal cancer	0.000226	0.0131	CcSEcCtD
Drospirenone—Norethindrone—ABCB1—esophageal cancer	0.000223	0.0331	CrCbGaD
Drospirenone—Mental disorder—Capecitabine—esophageal cancer	0.000218	0.0127	CcSEcCtD
Drospirenone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000207	0.012	CcSEcCtD
Drospirenone—Depression—Methotrexate—esophageal cancer	0.000206	0.012	CcSEcCtD
Drospirenone—Haemoglobin—Methotrexate—esophageal cancer	0.000186	0.0108	CcSEcCtD
Drospirenone—Haemorrhage—Methotrexate—esophageal cancer	0.000185	0.0108	CcSEcCtD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000183	0.0107	CcSEcCtD
Drospirenone—Erythema multiforme—Methotrexate—esophageal cancer	0.000175	0.0102	CcSEcCtD
Drospirenone—Nervous system disorder—Capecitabine—esophageal cancer	0.000173	0.0101	CcSEcCtD
Drospirenone—Skin disorder—Capecitabine—esophageal cancer	0.000172	0.00999	CcSEcCtD
Drospirenone—Angiopathy—Methotrexate—esophageal cancer	0.000168	0.00977	CcSEcCtD
Drospirenone—Mental disorder—Methotrexate—esophageal cancer	0.000162	0.00944	CcSEcCtD
Drospirenone—Hydrocortisone—ABCB1—esophageal cancer	0.000159	0.0237	CrCbGaD
Drospirenone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000153	0.00888	CcSEcCtD
Drospirenone—NR3C2—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000145	0.00131	CbGpPWpGaD
Drospirenone—AR—Androgen receptor signaling pathway—EGFR—esophageal cancer	0.000145	0.00131	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.000145	0.0013	CbGpPWpGaD
Drospirenone—Nausea—Cisplatin—esophageal cancer	0.000143	0.00829	CcSEcCtD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.000142	0.00128	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KMT2D—esophageal cancer	0.000142	0.00128	CbGpPWpGaD
Drospirenone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.000142	0.00127	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—BCL2—esophageal cancer	0.000141	0.00127	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—NOTCH3—esophageal cancer	0.000139	0.00125	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—ST6GAL1—esophageal cancer	0.000137	0.00123	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.000137	0.00123	CbGpPWpGaD
Drospirenone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000136	0.00793	CcSEcCtD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000136	0.00122	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SMG6—esophageal cancer	0.000136	0.00122	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NR1I2—esophageal cancer	0.000135	0.00121	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TLR4—esophageal cancer	0.000134	0.00121	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000134	0.00121	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000133	0.00119	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CDKN2A—esophageal cancer	0.000132	0.00119	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—BCL2—esophageal cancer	0.00013	0.00117	CbGpPWpGaD
Drospirenone—Progesterone—ABCB1—esophageal cancer	0.00013	0.0193	CrCbGaD
Drospirenone—Nervous system disorder—Methotrexate—esophageal cancer	0.000129	0.00751	CcSEcCtD
Drospirenone—PTGS2—Spinal Cord Injury—NOS2—esophageal cancer	0.000128	0.00115	CbGpPWpGaD
Drospirenone—Skin disorder—Methotrexate—esophageal cancer	0.000128	0.00743	CcSEcCtD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.000128	0.00115	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ADCYAP1—esophageal cancer	0.000127	0.00114	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—NOTCH2—esophageal cancer	0.000125	0.00112	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—EGFR—esophageal cancer	0.000124	0.00112	CbGpPWpGaD
Drospirenone—Testosterone—ABCB1—esophageal cancer	0.000123	0.0183	CrCbGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	0.000121	0.00109	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.000121	0.00109	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.00012	0.00108	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000117	0.00105	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.000117	0.00105	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.000117	0.00105	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—HIST1H2BM—esophageal cancer	0.000116	0.00104	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—WWOX—esophageal cancer	0.000116	0.00104	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—RB1—esophageal cancer	0.000114	0.00103	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000114	0.00102	CbGpPWpGaD
Drospirenone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000114	0.00661	CcSEcCtD
Drospirenone—BCHE—Metabolism—BLVRB—esophageal cancer	0.000113	0.00102	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SLC52A3—esophageal cancer	0.000113	0.00102	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—EP300—esophageal cancer	0.000112	0.00101	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CCND1—esophageal cancer	0.000112	0.001	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000111	0.001	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000111	0.000995	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FKBP1A—esophageal cancer	0.00011	0.000991	CbGpPWpGaD
Drospirenone—AR—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000109	0.000979	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—CDKN1A—esophageal cancer	0.000108	0.000971	CbGpPWpGaD
Drospirenone—PGR—Signaling by ERBB4—PIK3CA—esophageal cancer	0.000108	0.000971	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—WIF1—esophageal cancer	0.000108	0.000969	CbGpPWpGaD
Drospirenone—Nausea—Capecitabine—esophageal cancer	0.000105	0.00611	CcSEcCtD
Drospirenone—NR3C2—Gene Expression—SMAD4—esophageal cancer	0.000105	0.000943	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NR1I2—esophageal cancer	0.000103	0.000925	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—EP300—esophageal cancer	0.000103	0.000924	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000101	0.000911	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000101	0.000909	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000101	0.000905	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000101	0.000905	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CSNK1A1—esophageal cancer	9.93e-05	0.000894	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—NOTCH1—esophageal cancer	9.77e-05	0.000879	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—MYC—esophageal cancer	9.73e-05	0.000876	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	9.73e-05	0.000875	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CA1—esophageal cancer	9.63e-05	0.000867	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—SLC10A2—esophageal cancer	9.63e-05	0.000867	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	9.52e-05	0.000857	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—ACTB—esophageal cancer	9.45e-05	0.000851	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SLC52A3—esophageal cancer	9.31e-05	0.000838	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PFN1—esophageal cancer	9.29e-05	0.000836	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	9.26e-05	0.000833	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PSME1—esophageal cancer	8.98e-05	0.000808	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—PSME2—esophageal cancer	8.98e-05	0.000808	CbGpPWpGaD
Drospirenone—PTGS2—C-MYB transcription factor network—MYC—esophageal cancer	8.95e-05	0.000805	CbGpPWpGaD
Drospirenone—PTGS2—Disease—KMT2D—esophageal cancer	8.88e-05	0.000799	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—CREBBP—esophageal cancer	8.86e-05	0.000797	CbGpPWpGaD
Drospirenone—AR—Gene Expression—HIST1H2BM—esophageal cancer	8.82e-05	0.000794	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CA2—esophageal cancer	8.81e-05	0.000793	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	8.78e-05	0.00079	CbGpPWpGaD
Drospirenone—NR3C2—Generic Transcription Pathway—MYC—esophageal cancer	8.63e-05	0.000777	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	8.61e-05	0.000775	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—HSPA5—esophageal cancer	8.54e-05	0.000769	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—CCND1—esophageal cancer	8.5e-05	0.000765	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NOTCH3—esophageal cancer	8.47e-05	0.000763	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ELMO1—esophageal cancer	8.35e-05	0.000751	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—CALR—esophageal cancer	8.28e-05	0.000745	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PLCE1—esophageal cancer	8.19e-05	0.000737	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ADH7—esophageal cancer	8.19e-05	0.000737	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—AKAP13—esophageal cancer	8.16e-05	0.000734	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—GHRL—esophageal cancer	8.14e-05	0.000732	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	8.1e-05	0.000729	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	8.07e-05	0.000726	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of proteins—FBXW7—esophageal cancer	8.01e-05	0.00072	CbGpPWpGaD
Drospirenone—AR—Integrated Breast Cancer Pathway—TP53—esophageal cancer	7.99e-05	0.000719	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	7.89e-05	0.00071	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	7.85e-05	0.000706	CbGpPWpGaD
Drospirenone—Nausea—Methotrexate—esophageal cancer	7.82e-05	0.00455	CcSEcCtD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	7.81e-05	0.000703	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—BLVRB—esophageal cancer	7.8e-05	0.000702	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC52A3—esophageal cancer	7.8e-05	0.000702	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—NOTCH1—esophageal cancer	7.73e-05	0.000695	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NOTCH2—esophageal cancer	7.6e-05	0.000684	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HIST1H2BM—esophageal cancer	7.53e-05	0.000677	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PDE4D—esophageal cancer	7.46e-05	0.000671	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—NOTCH1—esophageal cancer	7.45e-05	0.00067	CbGpPWpGaD
Drospirenone—BCHE—Phospholipid metabolism—PIK3CA—esophageal cancer	7.42e-05	0.000667	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ADH1B—esophageal cancer	7.18e-05	0.000646	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GNG7—esophageal cancer	7.1e-05	0.000639	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—CREBBP—esophageal cancer	7e-05	0.00063	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	6.97e-05	0.000627	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FKBP1A—esophageal cancer	6.89e-05	0.00062	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TYMP—esophageal cancer	6.87e-05	0.000618	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	6.85e-05	0.000616	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PSME2—esophageal cancer	6.84e-05	0.000616	CbGpPWpGaD
Drospirenone—AR—Gene Expression—PSME1—esophageal cancer	6.84e-05	0.000616	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—MYC—esophageal cancer	6.82e-05	0.000613	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—CREBBP—esophageal cancer	6.75e-05	0.000607	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	6.74e-05	0.000606	CbGpPWpGaD
Drospirenone—PTGS2—Disease—WIF1—esophageal cancer	6.73e-05	0.000606	CbGpPWpGaD
Drospirenone—PTGS2—Disease—DOCK2—esophageal cancer	6.73e-05	0.000606	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP26A1—esophageal cancer	6.68e-05	0.000601	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—EGFR—esophageal cancer	6.67e-05	0.0006	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—XIAP—esophageal cancer	6.65e-05	0.000598	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CA1—esophageal cancer	6.63e-05	0.000597	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—SLC10A2—esophageal cancer	6.63e-05	0.000597	CbGpPWpGaD
Drospirenone—AR—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	6.62e-05	0.000596	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	6.54e-05	0.000589	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALOX15—esophageal cancer	6.51e-05	0.000586	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NOTCH3—esophageal cancer	6.46e-05	0.000581	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—SMAD4—esophageal cancer	6.38e-05	0.000574	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CTNNA1—esophageal cancer	6.29e-05	0.000566	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CXCL2—esophageal cancer	6.25e-05	0.000563	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CSNK1A1—esophageal cancer	6.21e-05	0.000559	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—TPI1—esophageal cancer	6.21e-05	0.000559	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTO1—esophageal cancer	6.21e-05	0.000559	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CA2—esophageal cancer	6.07e-05	0.000546	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALDOB—esophageal cancer	5.95e-05	0.000536	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	5.93e-05	0.000533	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PSME2—esophageal cancer	5.84e-05	0.000526	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PSME1—esophageal cancer	5.84e-05	0.000526	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ANXA1—esophageal cancer	5.81e-05	0.000523	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NOTCH2—esophageal cancer	5.79e-05	0.000521	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	5.78e-05	0.00052	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GAPDH—esophageal cancer	5.73e-05	0.000516	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CRABP1—esophageal cancer	5.68e-05	0.000511	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SST—esophageal cancer	5.65e-05	0.000509	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PLCE1—esophageal cancer	5.64e-05	0.000507	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ADH7—esophageal cancer	5.64e-05	0.000507	CbGpPWpGaD
Drospirenone—PTGS2—Spinal Cord Injury—TP53—esophageal cancer	5.6e-05	0.000504	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	5.59e-05	0.000503	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.57e-05	0.000502	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—GHRL—esophageal cancer	5.51e-05	0.000496	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH3—esophageal cancer	5.51e-05	0.000496	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—FBXW7—esophageal cancer	5.42e-05	0.000488	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GNG7—esophageal cancer	5.4e-05	0.000486	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	5.32e-05	0.000479	CbGpPWpGaD
Drospirenone—PGR—Generic Transcription Pathway—MYC—esophageal cancer	5.26e-05	0.000473	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ELMO1—esophageal cancer	5.22e-05	0.00047	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TPI1—esophageal cancer	5.1e-05	0.000459	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GSTO1—esophageal cancer	5.1e-05	0.000459	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ALDH2—esophageal cancer	5.06e-05	0.000455	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ADH1B—esophageal cancer	4.94e-05	0.000445	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH2—esophageal cancer	4.94e-05	0.000445	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ALDOB—esophageal cancer	4.89e-05	0.00044	CbGpPWpGaD
Drospirenone—AR—Gene Expression—SMAD4—esophageal cancer	4.86e-05	0.000438	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—GSTT1—esophageal cancer	4.81e-05	0.000433	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP2A6—esophageal cancer	4.76e-05	0.000428	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.74e-05	0.000427	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TYMP—esophageal cancer	4.73e-05	0.000425	CbGpPWpGaD
Drospirenone—PTGS2—Disease—GAPDH—esophageal cancer	4.71e-05	0.000424	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HIST1H2BM—esophageal cancer	4.71e-05	0.000424	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—NOTCH1—esophageal cancer	4.7e-05	0.000423	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	4.64e-05	0.000417	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP26A1—esophageal cancer	4.6e-05	0.000414	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	4.54e-05	0.000408	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS1—esophageal cancer	4.51e-05	0.000406	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ENO1—esophageal cancer	4.51e-05	0.000406	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALOX15—esophageal cancer	4.48e-05	0.000403	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PSME2—esophageal cancer	4.45e-05	0.0004	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PSME1—esophageal cancer	4.45e-05	0.0004	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TGFBR2—esophageal cancer	4.38e-05	0.000394	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—TPI1—esophageal cancer	4.27e-05	0.000385	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTO1—esophageal cancer	4.27e-05	0.000385	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—CREBBP—esophageal cancer	4.27e-05	0.000384	CbGpPWpGaD
Drospirenone—PTGS2—Disease—XIAP—esophageal cancer	4.16e-05	0.000374	CbGpPWpGaD
Drospirenone—NR3C2—Gene Expression—MYC—esophageal cancer	4.16e-05	0.000374	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—SMAD4—esophageal cancer	4.15e-05	0.000373	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALDOB—esophageal cancer	4.1e-05	0.000369	CbGpPWpGaD
Drospirenone—AR—Generic Transcription Pathway—MYC—esophageal cancer	4.01e-05	0.00036	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GAPDH—esophageal cancer	3.94e-05	0.000355	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.94e-05	0.000354	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CRABP1—esophageal cancer	3.91e-05	0.000352	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.88e-05	0.000349	CbGpPWpGaD
Drospirenone—PTGS2—Disease—B2M—esophageal cancer	3.87e-05	0.000348	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP1B1—esophageal cancer	3.84e-05	0.000345	CbGpPWpGaD
Drospirenone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.81e-05	0.000343	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GNG7—esophageal cancer	3.72e-05	0.000335	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ENO1—esophageal cancer	3.71e-05	0.000334	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PSME1—esophageal cancer	3.65e-05	0.000329	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PSME2—esophageal cancer	3.65e-05	0.000329	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CYP19A1—esophageal cancer	3.61e-05	0.000325	CbGpPWpGaD
Drospirenone—AR—Gene Expression—NOTCH1—esophageal cancer	3.58e-05	0.000323	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CALR—esophageal cancer	3.51e-05	0.000315	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ALDH2—esophageal cancer	3.48e-05	0.000313	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—HIF1A—esophageal cancer	3.4e-05	0.000306	CbGpPWpGaD
Drospirenone—PTGS2—Disease—FBXW7—esophageal cancer	3.39e-05	0.000305	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—GSTT1—esophageal cancer	3.31e-05	0.000298	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—HMOX1—esophageal cancer	3.29e-05	0.000296	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP2A6—esophageal cancer	3.28e-05	0.000295	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.26e-05	0.000294	CbGpPWpGaD
Drospirenone—AR—Gene Expression—CREBBP—esophageal cancer	3.25e-05	0.000292	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—KDR—esophageal cancer	3.25e-05	0.000292	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.23e-05	0.00029	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—ABCB1—esophageal cancer	3.16e-05	0.000284	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PTGS1—esophageal cancer	3.11e-05	0.000279	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ENO1—esophageal cancer	3.11e-05	0.000279	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PSME2—esophageal cancer	3.06e-05	0.000275	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PSME1—esophageal cancer	3.06e-05	0.000275	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOTCH1—esophageal cancer	3.06e-05	0.000275	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CREBBP—esophageal cancer	2.77e-05	0.00025	CbGpPWpGaD
Drospirenone—PTGS2—Disease—TGFBR2—esophageal cancer	2.74e-05	0.000247	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP1B1—esophageal cancer	2.64e-05	0.000238	CbGpPWpGaD
Drospirenone—PTGS2—Disease—SMAD4—esophageal cancer	2.6e-05	0.000234	CbGpPWpGaD
Drospirenone—PGR—Gene Expression—MYC—esophageal cancer	2.53e-05	0.000228	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—NOS3—esophageal cancer	2.48e-05	0.000223	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CYP19A1—esophageal cancer	2.48e-05	0.000223	CbGpPWpGaD
Drospirenone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.39e-05	0.000215	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—ERBB2—esophageal cancer	2.32e-05	0.000209	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—HMOX1—esophageal cancer	2.27e-05	0.000204	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.22e-05	0.0002	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—ABCB1—esophageal cancer	2.17e-05	0.000196	CbGpPWpGaD
Drospirenone—PTGS2—Disease—HIF1A—esophageal cancer	2.12e-05	0.000191	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—CREBBP—esophageal cancer	2.11e-05	0.00019	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CCND1—esophageal cancer	2.05e-05	0.000185	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—CDKN1A—esophageal cancer	1.99e-05	0.000179	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS2—esophageal cancer	1.93e-05	0.000174	CbGpPWpGaD
Drospirenone—AR—Gene Expression—MYC—esophageal cancer	1.93e-05	0.000174	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOTCH1—esophageal cancer	1.91e-05	0.000172	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—NOS3—esophageal cancer	1.89e-05	0.00017	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EP300—esophageal cancer	1.89e-05	0.00017	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CREBBP—esophageal cancer	1.74e-05	0.000156	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PTGS2—esophageal cancer	1.73e-05	0.000156	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—MYC—esophageal cancer	1.65e-05	0.000148	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.64e-05	0.000148	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—EGFR—esophageal cancer	1.61e-05	0.000145	CbGpPWpGaD
Drospirenone—PTGS2—Disease—NOS3—esophageal cancer	1.55e-05	0.00014	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—CREBBP—esophageal cancer	1.45e-05	0.000131	CbGpPWpGaD
Drospirenone—PTGS2—Disease—ERBB2—esophageal cancer	1.45e-05	0.000131	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—EP300—esophageal cancer	1.44e-05	0.000129	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—PIK3CA—esophageal cancer	1.4e-05	0.000126	CbGpPWpGaD
Drospirenone—PGR—Signaling Pathways—TP53—esophageal cancer	1.35e-05	0.000122	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—NOS3—esophageal cancer	1.3e-05	0.000117	CbGpPWpGaD
Drospirenone—PTGS2—Disease—CDKN1A—esophageal cancer	1.24e-05	0.000112	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EP300—esophageal cancer	1.18e-05	0.000106	CbGpPWpGaD
Drospirenone—BCHE—Metabolism—PIK3CA—esophageal cancer	1.06e-05	9.57e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—MYC—esophageal cancer	1.03e-05	9.27e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—EGFR—esophageal cancer	1.01e-05	9.06e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—EP300—esophageal cancer	9.9e-06	8.9e-05	CbGpPWpGaD
Drospirenone—PTGS2—Disease—PIK3CA—esophageal cancer	8.74e-06	7.87e-05	CbGpPWpGaD
Drospirenone—PTGS2—Metabolism—PIK3CA—esophageal cancer	7.32e-06	6.59e-05	CbGpPWpGaD
